|
2025
|
Invention
|
Method of administration and treatment.
Provided herein are formulations for topical and/or tran... |
|
2024
|
Invention
|
Buffering for non-alcoholic steatohepatitis and liver diseases.
The present disclosure relates t... |
|
|
Invention
|
Formulations for transdermal administration of active agents.
The present disclosure relates to ... |
|
|
Invention
|
Transdermal carrier.
Improved formulations for topical treatment that ensure at least localized ... |
|
|
Invention
|
Methods for treating gout and bone decalcification.
The present disclosure relates to transderma... |
|
|
Invention
|
Methods for treating inflammatory pain and bone decalcification.
The present disclosure relates ... |
|
2023
|
Invention
|
Transdermal penetrant formulations for administration of medicaments.
The present disclosure rel... |
|
|
Invention
|
Method of administration and treatment. Provided herein are formulations for topical and/or trans... |
|
|
Invention
|
Buffering for non-alcoholic steatohepatitis and liver diseases. e.g.,e.g., a non-alcoholic fatty ... |
|
|
Invention
|
Formulations for transdermal administration of active agents. The present disclosure relates to a... |
|
2022
|
Invention
|
Methods for treating inflammation and bone density disorder by transdermally administering buffer... |
|
|
Invention
|
Methods for treating gout and bone decalcification by transdermally administering buffering agent... |
|
|
Invention
|
Transdermal carrier. Improved formulations for topical treatment that ensure at least localized t... |
|
|
Invention
|
Topical delivery of buffering agents for prevention and treatment of viral infections.
Provided ... |
|
|
Invention
|
Topical cyclosporine for treating psoriasis and other ailments.
Disclosed herein is a transderma... |
|
|
Invention
|
Transdermal penetration by modulating epithelial junctions.
Embodiments include a transdermal de... |
|
|
Invention
|
Transdermal penetrant formulations for administration of medicaments. The present disclosure rela... |
|
|
Invention
|
Transdermal formulations for phosphodiesterase-5 inhibitors. The present disclosure relates to a ... |
|
2021
|
Invention
|
Transdermal penetrant formulations.
Disclosed herein is a transdermal delivery formulation for t... |
|
|
Invention
|
Inhibition of spontaneous metastasis via protein inhibitors of cysteine proteases.
Two disparate... |
|
|
Invention
|
Topical delivery of buffering agents for prevention and treatment of viral infections. Provided h... |
|
2020
|
Invention
|
Transdermal penetrant formulations containing cannabidiol.
Disclosed herein is a transdermal del... |
|
2019
|
Invention
|
Management of risk of cation overload and electrolyte imbalance with topically applied buffers.
... |
|
|
Invention
|
Methods and formulations for transdermal administration of dermal contouring agents.
Disclosed h... |
|
|
Invention
|
Formulations and methods for transdermal administration of ketones.
A formulation for transderma... |
|
|
Invention
|
Iron formulations for topical administration and methods of treatment of iron deficiency.
Provid... |
|
|
Invention
|
Transdermal penetrant formulations containing cannabidiol. Disclosed herein is a transdermal deli... |
|
2018
|
Invention
|
Topical applications of withaferin a.
This disclosure is directed to the topical/transdermal adm... |
|
|
Invention
|
Methods and formulations for transdermal administration of buffering agents.
A formulation for t... |
|
2017
|
Invention
|
Enhanced transdermal delivery of active agents.
Improved formulations that combine chemical perm... |
|
2015
|
Invention
|
Methods and formulations for transdermal administration.
Improved formulations for topical treat... |
